---
title: "Yakult Study Finds LcS Dairy Products Significantly Reduce Anemia Risk in Elderly"
type: "News"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/272339696.md"
datetime: "2026-01-13T01:08:25.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/272339696.md)
  - [en](https://longbridge.com/en/news/272339696.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/272339696.md)
---

> 支持的語言: [简体中文](https://longbridge.com/zh-CN/news/272339696.md) | [English](https://longbridge.com/en/news/272339696.md)


# Yakult Study Finds LcS Dairy Products Significantly Reduce Anemia Risk in Elderly

Yakult Honsha Co., Ltd. has announced the results of an epidemiological investigation conducted in collaboration with the Tokyo Metropolitan Institute for Geriatrics and Gerontology. The study examined the impact of habitual consumption of dairy products containing Lacticaseibacillus paracasei strain Shirota (LcS) on the incidence of anemia among elderly residents in Nakanojo Town, Gunma Prefecture. The findings indicated a significant reduction in the risk of anemia onset in individuals who regularly consumed LcS-containing dairy products. The results have already been published in the journal Beneficial Microbes under the title “Habitual consumption of fermented milk products containing Lacticaseibacillus paracasei strain Shirota and risk of anaemia in the elderly.” Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Yakult Honsha Co. Ltd. published the original content used to generate this news brief on January 13, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

## 相關資訊與研究

- [Ibiden Co.,Ltd.(TSE:4062) added to S&P TOPIX](https://longbridge.com/zh-HK/news/280996796.md)
- [Akebia Therapeutics R&D Day: Vafseo Growth Plan, Praliciguat Phase 2, New Kidney Pipeline Targets](https://longbridge.com/zh-HK/news/281552736.md)
- [Goodricke brews dairy bet as it looks beyond tea for business growth](https://longbridge.com/zh-HK/news/281317700.md)
- [Tranche Update on Ebara Corporation's Equity Buyback Plan announced on February 13, 2026.](https://longbridge.com/zh-HK/news/281422680.md)
- [Tranche Update on Nippon Yusen Kabushiki Kaisha's Equity Buyback Plan announced on May 8, 2025.](https://longbridge.com/zh-HK/news/281414712.md)